-
1
-
-
0027738820
-
The impact of congenital malformations on public health
-
Atlanta, Georgia: US Department of Health & Human Services, Center for Diseases Control
-
Sever L, Lynberg MC, Edmonds LD: The impact of congenital malformations on public health. In Congenital Malformations Surveillance. Atlanta, Georgia: US Department of Health & Human Services, Center for Diseases Control, 1993, 48:547-549.
-
(1993)
Congenital Malformations Surveillance
, vol.48
, pp. 547-549
-
-
Sever, L.1
Lynberg, M.C.2
Edmonds, L.D.3
-
3
-
-
0029069849
-
Young maternal age and congenital malformations: A population-based study
-
Croen LA, Shaw GM: Young maternal age and congenital malformations: a population-based study. Am J Public Health 1995, 85:710-713. Evaluation of the prevalence of congenital anomalies among mothers younger than 20 years of age compared with 25-29-year-old mothers from the California Birth Defects Monitoring Program.
-
(1995)
Am J Public Health
, vol.85
, pp. 710-713
-
-
Croen, L.A.1
Shaw, G.M.2
-
4
-
-
0028832419
-
Impact of prenatal diagnosis on the birth prevalence of neural tube defects, Atlanta, 1990-1991
-
Roberts HE, Moore CA, Cragan JD, Fernhoff PM, Kohury MJ: Impact of prenatal diagnosis on the birth prevalence of neural tube defects, Atlanta, 1990-1991. Pediatrics 1995, 96:880-883. A study that shows the reduction in the prevalence of NTDs from 1971 to 1990-1991, and estimates to what extent this reduction could be attributed to prenatal diagnosis.
-
(1995)
Pediatrics
, vol.96
, pp. 880-883
-
-
Roberts, H.E.1
Moore, C.A.2
Cragan, J.D.3
Fernhoff, P.M.4
Kohury, M.J.5
-
6
-
-
0029967412
-
Effect of increasing dietary folate on red-cell folate: Implications for prevention of neural tube defects
-
Cuskelly GJ, McNulty H, Scott JM: Effect of increasing dietary folate on red-cell folate: implications for prevention of neural tube defects. Lancet 1996, 347:657-658. This study uses assessment of changes in red-cell folate to evaluate the effectiveness of three different ways recommended to achieve an intake of 400 μg daily of folic acid.
-
(1996)
Lancet
, vol.347
, pp. 657-658
-
-
Cuskelly, G.J.1
McNulty, H.2
Scott, J.M.3
-
7
-
-
0029151571
-
Risk of orofacial clefts in children born to women using multivitamins containing folic acid periconceptionally
-
Shaw GM, Lammer EJ, Wasserman CR, O'Malley CD, Tolarova MM: Risk of orofacial clefts in children born to women using multivitamins containing folic acid periconceptionally. Lancet 1995, 345:393-396. The objective was to investigate whether maternal multivitamin use reduced the risk of delivering offspring with orafacial clefts.
-
(1995)
Lancet
, vol.345
, pp. 393-396
-
-
Shaw, G.M.1
Lammer, E.J.2
Wasserman, C.R.3
O'Malley, C.D.4
Tolarova, M.M.5
-
8
-
-
0027298758
-
Prevention of congenital abnormalities by periconceptional multivitamin supplementation
-
Czeizel AE: Prevention of congenital abnormalities by periconceptional multivitamin supplementation. BMJ 1993, 306:1645-1648.
-
(1993)
BMJ
, vol.306
, pp. 1645-1648
-
-
Czeizel, A.E.1
-
9
-
-
0026783047
-
Previous miscarriage and stillbirth as risk factors for other unfavorable outcomes in the next pregnancy
-
Paz JE, Otaño L, Gadow EC, Castilla EC: Previous miscarriage and stillbirth as risk factors for other unfavorable outcomes in the next pregnancy. Br J Obstet Gynaecol 1992, 99:808-812.
-
(1992)
Br J Obstet Gynaecol
, vol.99
, pp. 808-812
-
-
Paz, J.E.1
Otaño, L.2
Gadow, E.C.3
Castilla, E.C.4
-
10
-
-
0002673014
-
Guidance on Terminology
-
Wald NJ: Guidance on Terminology. J Med Screening 1994, 1:76.
-
(1994)
J Med Screening
, vol.1
, pp. 76
-
-
Wald, N.J.1
-
11
-
-
0029612238
-
Towards informed decisions about prenatal testing: A review
-
Marteau TM: Towards informed decisions about prenatal testing: a review. Prenat Diagn 1995, 15:1215-1226. A review on how best to inform patients about prenatal screening and their reproductive options following diagnosis of a congenital malformation. To this purpose, several approaches are described such as staff- and patient-focused interventions and training.
-
(1995)
Prenat Diagn
, vol.15
, pp. 1215-1226
-
-
Marteau, T.M.1
-
12
-
-
0029587354
-
Associations between adverse perinatal outcome and serially obtained second- and third-trimester maternal serum α-fetoprotein measurements
-
Simpson JL, Palomaki GE, Mercer B, Haddow JE, Andersen R, Sibai B, Elias S: Associations between adverse perinatal outcome and serially obtained second- and third-trimester maternal serum α-fetoprotein measurements. Am J Obstet Gynecol 1995, 173:1742-1748. A cohort study with obstetric outcome of 650 women with a singleton pregnancy without a NTD. Pre-term, premature rupture of the membranes, pre-term birth, and low birthweight were found to be associated with second-but not third-trimester maternal serum AFP elevations.
-
(1995)
Am J Obstet Gynecol
, vol.173
, pp. 1742-1748
-
-
Simpson, J.L.1
Palomaki, G.E.2
Mercer, B.3
Haddow, J.E.4
Andersen, R.5
Sibai, B.6
Elias, S.7
-
13
-
-
0026645888
-
Prenatal screening for Down's syndrome with use of maternal serum markers
-
Haddow JE, Palomaki GE, Knight GJ, Williams J, Pulkkinen A, Canick JA, Saller DN, Barsel Bowers G: Prenatal screening for Down's syndrome with use of maternal serum markers. N Engl J Med 1992, 327:588-593.
-
(1992)
N Engl J Med
, vol.327
, pp. 588-593
-
-
Haddow, J.E.1
Palomaki, G.E.2
Knight, G.J.3
Williams, J.4
Pulkkinen, A.5
Canick, J.A.6
Saller, D.N.7
Barsel Bowers, G.8
-
14
-
-
0026692180
-
Antenatal maternal serum screening for Down's syndrome: Results of a demonstration project
-
Wald NJ, Kennard A, Densem JW, Cuckle HS, Chard T, Butler L: Antenatal maternal serum screening for Down's syndrome: results of a demonstration project BMJ 1992, 305:391-394
-
(1992)
BMJ
, vol.305
, pp. 391-394
-
-
Wald, N.J.1
Kennard, A.2
Densem, J.W.3
Cuckle, H.S.4
Chard, T.5
Butler, L.6
-
15
-
-
0027940395
-
Serum PAPP-A and free beta-hCG are first trimester screening markers for Down's Syndrome
-
Brambati B, Tului L, Bonacchi I, Shrimanker K, Suzuki Y, Grudzinskas JG: Serum PAPP-A and free beta-hCG are first trimester screening markers for Down's Syndrome. Prenat Diagn 1994, 14:1043-1047.
-
(1994)
Prenat Diagn
, vol.14
, pp. 1043-1047
-
-
Brambati, B.1
Tului, L.2
Bonacchi, I.3
Shrimanker, K.4
Suzuki, Y.5
Grudzinskas, J.G.6
-
16
-
-
0029002236
-
First trimester fetal nuchal translucency: Problems with screening the general population 1
-
Roberts LJ, Bewley S, Mackinson AM, Rodeck CH: First trimester fetal nuchal translucency: problems with screening the general population 1. Br J Obstet Gynaecol 1995, 102:381-385.
-
(1995)
Br J Obstet Gynaecol
, vol.102
, pp. 381-385
-
-
Roberts, L.J.1
Bewley, S.2
Mackinson, A.M.3
Rodeck, C.H.4
-
17
-
-
0029181608
-
The implementation of first trimester scanning at 10-13 weeks' gestation and the measurement of fetal nuchal translucency thickness in two maternity units
-
Pandya PP, Goldberg H, Walton B, Riddle A, Shelley S, Snijders RJM, Nicolaides KH: The implementation of first trimester scanning at 10-13 weeks' gestation and the measurement of fetal nuchal translucency thickness in two maternity units. Ultrasound Obstet Gynecol 1995, 5:20-25.
-
(1995)
Ultrasound Obstet Gynecol
, vol.5
, pp. 20-25
-
-
Pandya, P.P.1
Goldberg, H.2
Walton, B.3
Riddle, A.4
Shelley, S.5
Snijders, R.J.M.6
Nicolaides, K.H.7
-
18
-
-
0027962426
-
Maternal serum pregnancy-associated placental protein A and fetal nuchal translucency thickness for the prediction of fetal trisomies in early pregnancy
-
Bizot ML, Snijders RJM, Bersinger NA, Kuhn P, Nicolaides KH: Maternal serum pregnancy-associated placental protein A and fetal nuchal translucency thickness for the prediction of fetal trisomies in early pregnancy. Obstet Gynecol 1994, 84:918-922.
-
(1994)
Obstet Gynecol
, vol.84
, pp. 918-922
-
-
Bizot, M.L.1
Snijders, R.J.M.2
Bersinger, N.A.3
Kuhn, P.4
Nicolaides, K.H.5
-
19
-
-
0028929622
-
Maternal serum hCG and fetal nuchal translucency thickness for the prediction of fetal trisomies in the first trimester of pregnancy
-
Bizot ML, Snijders RJM, Butler J, Bersinger NA, Nicolaides KH: Maternal serum hCG and fetal nuchal translucency thickness for the prediction of fetal trisomies in the first trimester of pregnancy. Br J Obstet Gynaecol 1995, 102:127-132. A retrospective study indicating that screening for trisomies can be achieved by combining determination of fetal nuchal translucency thickness and maternal serum biochemistry.
-
(1995)
Br J Obstet Gynaecol
, vol.102
, pp. 127-132
-
-
Bizot, M.L.1
Snijders, R.J.M.2
Butler, J.3
Bersinger, N.A.4
Nicolaides, K.H.5
-
20
-
-
0029587397
-
First trimester serum screening for Down's Syndrome
-
Wald NJ, Kennard A, Hackshaw AK: First trimester serum screening for Down's Syndrome. Prenat Diagn 1995, 15:1227-1240. A review of the published literature on early screening and its efficacy, and the results from a multi-centre study on ultrasound markers for Down's syndrome at 8-14 weeks' pregnancy.
-
(1995)
Prenat Diagn
, vol.15
, pp. 1227-1240
-
-
Wald, N.J.1
Kennard, A.2
Hackshaw, A.K.3
-
21
-
-
0027300745
-
Does routine ultrasound scanning improve outcoming in pregnancy? Meta-analysis of various outcome measures
-
Bucher H, Schmidt J: Does routine ultrasound scanning improve outcoming in pregnancy? Meta-analysis of various outcome measures. BMJ 1993, 307:13-17.
-
(1993)
BMJ
, vol.307
, pp. 13-17
-
-
Bucher, H.1
Schmidt, J.2
-
22
-
-
0028018294
-
A randomized trial of prenatal outcome of anomalous fetuses
-
Crane J, LeFevre M, Winborn R, Evans J, Ewigman B, Bain R, Frigoletto E, McNellis D, and the RADIUS Study Group: A randomized trial of prenatal outcome of anomalous fetuses. Am J Obstet Gynecol 1994, 171:392-399.
-
(1994)
Am J Obstet Gynecol
, vol.171
, pp. 392-399
-
-
Crane, J.1
LeFevre, M.2
Winborn, R.3
Evans, J.4
Ewigman, B.5
Bain, R.6
Frigoletto, E.7
McNellis, D.8
-
23
-
-
0028824789
-
Is polyhydramnios in an ultrasonographically normal fetus an indication for genetic evaluation?
-
Barnhard Y, Bar-Hava I, Divon MY: Is polyhydramnios in an ultrasonographically normal fetus an indication for genetic evaluation? Am J Obstet Gynecol 1995, 173:1523-1527. A prospective study of 2730 third-trimester pregnant women to determine the frequency of chromosomal anomalies in cases of polyhydramnios. Growth-retarded fetuses with polyhydramnios warrant genetic evaluation, which was found not to be absolutely indicated in patients with polyhydramnios and a sonographically normal fetus.
-
(1995)
Am J Obstet Gynecol
, vol.173
, pp. 1523-1527
-
-
Barnhard, Y.1
Bar-Hava, I.2
Divon, M.Y.3
-
24
-
-
0029618703
-
Ultrasound screening for fetal abnormalities
-
Chitty L: Ultrasound screening for fetal abnormalities. Prenat Diagn 1995, 15:1241-1257. A review on routine ultrasound screening studies and alternative anomaly screening policies. The majority of routine anomaly scanning is done in the second trimester, but there may be a case for screening at other times in pregnancy.
-
(1995)
Prenat Diagn
, vol.15
, pp. 1241-1257
-
-
Chitty, L.1
-
25
-
-
0029180678
-
Chromosomal defects and outcome in 1015 fetuses with increased nuchal translucency
-
Pandya PP, Kondylios A, Hilbert I, Snijders RJM, Nicolaides KH: Chromosomal defects and outcome in 1015 fetuses with increased nuchal translucency. Ultrasound Obstet Gynecol 1995, 5:155-19.
-
(1995)
Ultrasound Obstet Gynecol
, vol.5
, pp. 155-219
-
-
Pandya, P.P.1
Kondylios, A.2
Hilbert, I.3
Snijders, R.J.M.4
Nicolaides, K.H.5
-
26
-
-
0028198758
-
Epidemiology of congenital heart disease in the United States
-
Gillum RF: Epidemiology of congenital heart disease in the United States. Am Heart J 1994, 127:919-927.
-
(1994)
Am Heart J
, vol.127
, pp. 919-927
-
-
Gillum, R.F.1
-
28
-
-
0029079985
-
Echocardiography detection of congenital heart disease in the fetus: Present and future
-
Lindsey DA: Echocardiography detection of congenital heart disease in the fetus: present and future. Br Heart J 1995, 74:103-106. A study reporting that improved resolution of ultrasound equipment and the addition of pulsed, continuous wave and colour flow Doppler would allow the prenatal detection of cardiac malformations.
-
(1995)
Br Heart J
, vol.74
, pp. 103-106
-
-
Lindsey, D.A.1
-
29
-
-
0029401749
-
Fetal heart screening in low-risk pregnancies
-
Rustico MA, Benettoni A, D'Ottavio G, Maieron A, Fischer-Tamaro I, Conoscenti G, Meir Y, Montesano M, Cattaneo A, Mandruzzato G: Fetal heart screening in low-risk pregnancies. Ultrasound Obstet Gynecol 1995, 6:313-319.
-
(1995)
Ultrasound Obstet Gynecol
, vol.6
, pp. 313-319
-
-
Rustico, M.A.1
Benettoni, A.2
D'Ottavio, G.3
Maieron, A.4
Fischer-Tamaro, I.5
Conoscenti, G.6
Meir, Y.7
Montesano, M.8
Cattaneo, A.9
Mandruzzato, G.10
-
30
-
-
0029316774
-
Prenatal detection of heart defects at the routine fetal examination at 18 weeks in a non-selected population
-
Tegnander E, Eik-Nes SH, Johansen OJ, Linker DT: Prenatal detection of heart defects at the routine fetal examination at 18 weeks in a non-selected population. Ultrasound Obstet Gynecol 1995, 5:372-380.
-
(1995)
Ultrasound Obstet Gynecol
, vol.5
, pp. 372-380
-
-
Tegnander, E.1
Eik-Nes, S.H.2
Johansen, O.J.3
Linker, D.T.4
-
31
-
-
0029050851
-
Fetal echocardiography: Retrospective review of clinical experience and an evaluation of indications
-
Cooper MJ, Enderlein MA, Dyson DC, Rogé CL, Tarnoff H: Fetal echocardiography: retrospective review of clinical experience and an evaluation of indications. Obsret Gynecol 1995, 86:577-582.
-
(1995)
Obsret Gynecol
, vol.86
, pp. 577-582
-
-
Cooper, M.J.1
Enderlein, M.A.2
Dyson, D.C.3
Rogé, C.L.4
Tarnoff, H.5
-
32
-
-
0029001706
-
The accuracy of antenatal fetal echocardiography screening in high- and low-risk patients
-
Williams JO: The accuracy of antenatal fetal echocardiography screening in high- and low-risk patients. Am J Obstet Gynecol 1995, 172:1741-1749. A two-cohort prospective study showing poor diagnostic accuracy of the standard four-chamber and left ventricular outflow tract views in low-risk patients for the diagnosis of structural cardiac anomalies.
-
(1995)
Am J Obstet Gynecol
, vol.172
, pp. 1741-1749
-
-
Williams, J.O.1
|